Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results
Peter A Kavsak1, Ola Hammarsten2, Andrew Worster1
1McMaster University, Hamilton, Ontario, Canada.
Insights
Cardiac troponin is a key prognostic indicator for COVID-19 patients, but its interpretation and role require further study. This review examines SARS-CoV-2
Area of Science:
- Cardiology
- Infectious Diseases
- Biomarkers
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impact the cardiovascular system.
- Elevated cardiac troponin levels are recognized as a significant prognostic marker in hospitalized COVID-19 patients.
- Early pandemic literature revealed considerable uncertainty regarding the reporting, interpretation, and underlying pathophysiology of increased cardiac troponin in COVID-19.
Purpose of the Study:
- To review the pathophysiology of SARS-CoV-2 and its effects on the cardiovascular system.
- To critically evaluate the strengths and limitations of studies assessing cardiac troponin in COVID-19 patients.
- To propose recommended cardiac troponin testing strategies for different phases of COVID-19 illness and recovery.
Main Methods:
- Literature review of studies on SARS-CoV-2, cardiovascular effects, and cardiac troponin.
- Analysis of existing research to identify trends, inconsistencies, and knowledge gaps.
- Synthesis of findings to develop evidence-based recommendations for clinical practice.
Main Results:
- The review highlights the established link between SARS-CoV-2 infection and cardiovascular complications.
- It identifies variability in study methodologies and reporting standards for cardiac troponin assays.
- Gaps in understanding the precise mechanisms and clinical utility of troponin elevation in COVID-19 are noted.
Conclusions:
- Cardiac troponin plays a crucial role in prognostication for COVID-19 patients.
- Further well-designed research is essential to clarify the role and optimize testing strategies for cardiac troponin in COVID-19.
- Standardized approaches to troponin testing are needed for consistent patient management.
Background:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged late in 2019 causing COVID-19 (coronavirus disease-2019) may adversely affect the cardiovascular system. Publications from Asia, Europe, and North America have identified cardiac troponin as an important prognostic indicator for patients hospitalized with COVID-19. We recognized from publications within the first 6 months of the pandemic that there has been much uncertainty on the reporting, interpretation, and pathophysiology of an increased cardiac troponin concentration in this setting.
Content:
The purpose of this mini-review is: a) to review the pathophysiology of SARS-CoV-2 and the cardiovascular system, b) to overview the strengths and weaknesses of selected studies evaluating cardiac troponin in patients with COVID-19, and c) to recommend testing strategies in the acute period, in the convalescence period and in long-term care for patients who have become ill with COVID-19.
Summary:
This review provides important educational information and identifies gaps in understanding the role of cardiac troponin and COVID-19. Future, properly designed studies will hopefully provide the much-needed evidence on the path forward in testing cardiac troponin in patients with COVID-19.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT
Myocarditis III: Medical Management
